Global Transcatheter Aortic Valve Replacement (TAVR) Market Gains from Competition against Surgical Aortic Valve Replacement


Published Date : May 02, 2017

ALBANY, New York, May 2, 2017 – The global transcatheter aortic valve replacement (TAVR) market is prognosticated to invite a commendable growth while rising at a 18.30% CAGR between 2017 and 2022, according to a report included by MarketResearchReports.biz in its healthcare depository. The report bears the title “Global Transcatheter Aortic Valve Replacement (TAVR) Market: Analysis By Type of Approach (Transfemoral And Transapical), By Region, By Country: Opportunities And Forecast (2017-2022) - By Region (North America, Europe, Asia Pacific, RoW); By Country (U.S., Canada, Germany, France, U.K., China, India, Japan, Brazil, South Africa).”

The pioneering furtherance of the TAVR technique in the cardiovascular surgery and interventional cardiology medical domains is expected to augur well for the world TAVR market. Even though surgical aortic valve replacement has had an impact on the medical field as a standard treatment, a patient count of almost 30.0% is not regarded fit for conventional open heart surgeries. This could be due to the presence of sundry comorbidities and advanced age.

However, TAVR has emerged as a better option promising improved outcomes and a minimally invasive type of treatment. Elevating healthcare expenses in less developed nations, approvals for novel devices, surging awareness about less invasive devices, and the ballooning size of geriatric population worldwide are some of the leading factors stimulating the growth of the international TAVR market.

The U.S. is prophesied to experience a heightened adoption of TAVR treatments. Asia Pacific could hold on to a higher rate of advancement in the international TAVR market. The rise of the Asia Pacific TAVR market is envisaged to be driven by the consciousness about technologically sophisticated heart valve therapies, inflating penetration rate, and improvement in healthcare expenditure. Nevertheless, Europe could register a king’s share in the international TAVR market during the course of the forecast period.

For Sample Copy, click here: http://www.marketresearchreports.biz/sample/sample/1064494

The authors of this worldwide TAVR market research report have carefully analyzed the transapical and transfemoral types of approach. Besides this, the report buyers are provided access to a comprehensive geographical reports across several regions and countries. Growth factors, market shares and size, market deterrents and opportunities, competitive landscape, and more aspects of the worldwide TAVR market are profoundly discussed in the report.

One of the most productive portions of the publication incorporates strategic recommendations designed to help players enter or dominate the worldwide TAVR market. In this regard, the analysts have recommended players to focus on the commercialization and development of TAVR therapies.

The company profiling section sheds light on the critical information about some of the superior organizations operating in the international TAVR market such as Meril Life Sciences Pvt. Ltd., JenaValve Technology Inc., St. Jude Medical Inc., Boston Scientific Corporation, Medtronic Plc, and Edwards Lifesciences Corporation. In addition to that, the report has stressed on company share and country pricing and volume reports of the international TAVR market in the competitive landscape section.

To order report Call Toll Free: 866-997-4948 or send an email on sales@marketresearchreports.biz